Found: 5
Select item for more details and to access through your institution.
Hematopoietic expression of a chimeric murine‐human CALR oncoprotein allows the assessment of anti‐CALR antibody immunotherapies in vivo.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. 698, doi. 10.1002/ajh.26171
- By:
- Publication type:
- Article
5‐Arylidene‐2‐(4‐hydroxyphenyl)aminothiazol‐4(5H)‐ones with selective inhibitory activity against some leukemia cell lines.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000342
- By:
- Publication type:
- Article
High-throughput drug screening identifies the ATR-CHK1 pathway as a therapeutic vulnerability of CALR mutated hematopoietic cells.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00531-2
- By:
- Publication type:
- Article
Progress in elucidation of molecular pathophysiology of myeloproliferative neoplasms and its application to therapeutic decisions.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article